-
Je něco špatně v tomto záznamu ?
The effect of oxime reactivators on muscarinic receptors: functional and binding examinations
O. Soukup, UK. Kumar, J. Proska, L. Bratova, A. Adem, D. Jun, J. Fusek, K. Kuca, G. Tobin
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- acetylcholinesterasa metabolismus MeSH
- agonisté muskarinových receptorů farmakologie MeSH
- antagonisté muskarinových receptorů farmakologie MeSH
- chinuklidinylbenzilát metabolismus MeSH
- elektrická stimulace MeSH
- krysa rodu rattus MeSH
- oximy metabolismus farmakologie MeSH
- oxotremorin analogy a deriváty farmakologie MeSH
- potkani Wistar MeSH
- pyridinové sloučeniny metabolismus farmakologie MeSH
- reaktivátory cholinesterasy metabolismus farmakologie MeSH
- receptory muskarinové účinky léků MeSH
- receptory spřažené s G-proteiny metabolismus MeSH
- srdeční frekvence účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The antidotal treatment of organophosphorus poisoning is still a problematic issue since no versatile antidote has been developed yet. In our study, we focused on an interesting property, which does not relate to the reactivation of inhibited acetylcholinesterase (AChE) of some oximes, but refers to their anti-muscarinic effects which may contribute considerably to their treatment efficacy. One standard reactivator (HI-6) and two new compounds (K027 and K203) have been investigated for their antimuscarinic properties. Anti-muscarinic effects were studies by means of an in vitro stimulated atrium preparation (functional test), the [(3)H]-QNB binding assay and G-protein coupled receptor assay (GPCR, beta-Arrestin Assay). Based on the functional data HI-6 demonstrates the highest anti-muscarinic effect. However, only when comparing [(3)H]-QNB binding results and GPCR data, K203 shows a very promising compound with regard to anti-muscarinic potency. The therapeutic impact of these findings has been discussed.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022248
- 003
- CZ-PrNML
- 005
- 20160321160655.0
- 007
- ta
- 008
- 120806s2011 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.etap.2011.01.003 $2 doi
- 035 __
- $a (PubMed)21787706
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Soukup, Ondřej $u Department of Toxicology, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove 50001, Czech Republic $7 xx0253350
- 245 14
- $a The effect of oxime reactivators on muscarinic receptors: functional and binding examinations / $c O. Soukup, UK. Kumar, J. Proska, L. Bratova, A. Adem, D. Jun, J. Fusek, K. Kuca, G. Tobin
- 520 9_
- $a The antidotal treatment of organophosphorus poisoning is still a problematic issue since no versatile antidote has been developed yet. In our study, we focused on an interesting property, which does not relate to the reactivation of inhibited acetylcholinesterase (AChE) of some oximes, but refers to their anti-muscarinic effects which may contribute considerably to their treatment efficacy. One standard reactivator (HI-6) and two new compounds (K027 and K203) have been investigated for their antimuscarinic properties. Anti-muscarinic effects were studies by means of an in vitro stimulated atrium preparation (functional test), the [(3)H]-QNB binding assay and G-protein coupled receptor assay (GPCR, beta-Arrestin Assay). Based on the functional data HI-6 demonstrates the highest anti-muscarinic effect. However, only when comparing [(3)H]-QNB binding results and GPCR data, K203 shows a very promising compound with regard to anti-muscarinic potency. The therapeutic impact of these findings has been discussed.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a reaktivátory cholinesterasy $x metabolismus $x farmakologie $7 D002801
- 650 _2
- $a elektrická stimulace $7 D004558
- 650 _2
- $a srdeční frekvence $x účinky léků $7 D006339
- 650 _2
- $a agonisté muskarinových receptorů $x farmakologie $7 D018721
- 650 _2
- $a antagonisté muskarinových receptorů $x farmakologie $7 D018727
- 650 _2
- $a oximy $x metabolismus $x farmakologie $7 D010091
- 650 _2
- $a oxotremorin $x analogy a deriváty $x farmakologie $7 D010095
- 650 _2
- $a pyridinové sloučeniny $x metabolismus $x farmakologie $7 D011726
- 650 _2
- $a chinuklidinylbenzilát $x metabolismus $7 D011813
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a receptory spřažené s G-proteiny $x metabolismus $7 D043562
- 650 _2
- $a receptory muskarinové $x účinky léků $7 D011976
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kumar, U. K. $u Institute of Neuroscience and Physiology, Department of Pharmacology, The Sahlgrenska Academy at University of Gothenburg, Sweden
- 700 1_
- $a Proška, Jan $7 _BN001198 $u CTU in Prague, Faculty of Nuclear Sciences and Physical Engineering, V Holesovickach 2, 180 00 Prague 8, Czech Republic
- 700 1_
- $a Bratova, L. $u Institute of Neuroscience and Physiology, Department of Pharmacology, The Sahlgrenska Academy at University of Gothenburg, Sweden
- 700 1_
- $a Adem, A. $u Department of Pharmacology and Therapeutics, Faculty of Medicine, United Arab Emirates University, Al Ain, United Arab Emirates $7 gn_A_00001724
- 700 1_
- $a Jun, Daniel, $d 1976- $7 xx0040498 $u Department of Toxicology, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove 50001, Czech Republic; Center of Advanced Studies, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove 50001, Czech Republic
- 700 1_
- $a Fusek, Josef, $d 1945- $7 nlk20000076283 $u Department of Toxicology, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Králove, Czech Republic
- 700 1_
- $a Kuča, Kamil, $d 1978- $7 xx0041831 $u Department of Toxicology, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove 50001, Czech Republic; Center of Advanced Studies, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove 50001, Czech Republic
- 700 1_
- $a Tobin, G. $u Institute of Neuroscience and Physiology, Department of Pharmacology, The Sahlgrenska Academy at University of Gothenburg, Sweden
- 773 0_
- $w MED00008557 $t Environmental toxicology and pharmacology $x 1872-7077 $g Roč. 31, č. 3 (2011), s. 364-370
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21787706 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120806 $b ABA008
- 991 __
- $a 20160321160721 $b ABA008
- 999 __
- $a ok $b bmc $g 944161 $s 779545
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 31 $c 3 $d 364-370 $e 20110128 $i 1872-7077 $m Environmental toxicology and pharmacology $n Environ. toxicol. pharmacol. $x MED00008557
- LZP __
- $b NLK111 $a Pubmed-20120806/12/01